This inventor holds 8 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 7 EPO patents. Top assignees: Université´ D'aix-Marseille, Centre National De La Recherche Scientifique, National Institute of Health and Medical Research. Active years: 2014-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
4 out of 237 
3 out of 5,383 
3 out of 1,853 
Years Active: 2014-2023
Title: The Innovative Contributions of Jean-Michel Brunel
Introduction
Jean-Michel Brunel is a prominent inventor based in Marseilles, France. He has made significant contributions to the field of antimicrobial agents, holding a total of 8 patents. His work focuses on developing innovative solutions to combat resistant bacteria and infections.
Latest Patents
Among his latest patents are "Motuporamine derivatives as antimicrobial agents and antibiotic enhancers against resistant gram-negative bacteria" and "Amide derivatives of squalamine for the treatment of infections." The first patent addresses the use of Motuporamine agents that exhibit antimicrobial activity. The second patent details a compound designed to treat various infections, including bacterial, fungal, viral, or parasitic infections. This compound is characterized by a specific formula that includes various groups and their stereoisomers, as well as pharmaceutical compositions that incorporate this compound.
Career Highlights
Jean-Michel Brunel has worked with esteemed institutions such as the Institut National de la Santé et de la Recherche Médicale and the Université d'Aix-Marseille. His career is marked by a commitment to advancing medical research and developing effective treatments for infections.
Collaborations
Some of his notable coworkers include Otto Phanstiel and Jean-Pascal Marc. Their collaborative efforts have contributed to the success of his research and patent developments.
Conclusion
Jean-Michel Brunel's innovative work in the field of antimicrobial agents showcases his dedication to addressing critical health challenges. His patents reflect a significant advancement in the treatment of infections, highlighting the importance of continued research and innovation in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile